Use of long-acting GLP-I receptor agonists to improve insulin sensitivity and lipid profiles

Details for Australian Patent Application No. 2007336767 (hide)

Owner Centocor Ortho Biotech Inc.

Inventors Stojanovic-Susulic, Vedrana; O'Neil, Karyn T.; Picha, Kristen

Agent Shelston IP

Pub. Number AU-A-2007336767

PCT Pub. Number WO2008/080042

Priority 60/871,142 21.12.06 US

Filing date 21 December 2007

Wipo publication date 3 July 2008

International Classifications

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/080042 Priority application(s): WO2008/080042

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007336770-DR6 antibodies inhibiting the binding of DR6 to APP, and uses thereof in treating neurological disorders

2007336764-Transmission with resistance torque control